glp 1 bone density loss GLP-1s may increase risk of osteoporosis and gout, new research finds GLP-1s and bone loss!

This paper reviews the physiological, pharmacologic, and clinical foundations linking GLP-1 RA therapy to reproductive outcomes

Learn why the FDA says these products werent FDA-approved and how you could recover money.

Objective To assess whether use of glucagon-like peptide-1 (GLP-1) receptor agonists before upper gastrointestinal endoscopy is associated with increased risk of pulmonary aspiration or discontinuation of the procedure compared with sodium-glucose cotransporter-2 (SGLT-2) inhibitors

Developments in our understanding of gastroparesis have now demonstrated dysfunction in these systems, thus disrupting normal gastric emptying

All of these unanswered questions only add to the urgency of determining who is most likely to benefit from GLP-1s. : Luliia Burmistrova / Getty

Gastrointestinal symptoms such as nausea, constipation, and indigestion are most common and usually subside as your body adjusts